NDC properties for "timolol PF 0.5 % Ophthalmic Solution" (RxCUI 1922894)
About this data
The tables show NDC propoerties for timolol PF 0.5 % Ophthalmic Solution with the RxCUI 1922894
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol PF 0.5 % Ophthalmic Solution (RxCUI 1922894)
| ANDA | ANDA216533 |
|---|---|
| ANDA | ANDA216596 |
| ANDA | ANDA217195 |
| MMSL_CODE | BD32889 |
| MMSL_CODE | CD32889 |
| RxCUI | 1922894 |
| SPL_SET_ID | 036dc753-1698-4c69-9bcf-752c7061203c |
| SPL_SET_ID | 0c488889-6c37-44a2-94e2-97f98d48d6fb |
| SPL_SET_ID | 4c4318b3-9865-4172-a7bd-9e68913eca1e |
| SPL_SET_ID | 79b223e4-d929-4667-8149-e79bfab13fdf |
| SPL_SET_ID | b969bb47-6b4a-46ee-93cc-52faee4369c4 |
| SPL_SET_ID | ea585fe8-3356-4f08-8078-34e8ab5de37e |
| VUID | 4013431 |
| Prescribable Synonym | timolol PF 0.5 % Ophthalmic Solution |
| RXNAV_STR | Preservative-Free timolol 5 MG/ML Ophthalmic Solution |
| RxNorm Name | Preservative-Free timolol 5 MG/ML Ophthalmic Solution |
| RxNorm Synonym | timolol PF 0.5 % Ophthalmic Solution |
| RxNorm Synonym | timolol PF 5 MG/ML (as timolol maleate 6.8 MG/ML) Ophthalmic Solution |
| Related queries | Interactions (for RxCUI 1922894) |
NDC Properties
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |
NDC Item 17478018924
| NDC 9 | 17478-189 |
|---|---|
| NDC 10 | 17478-189-24 |
| NDC Item | 17478018924 |
| Packaging | 12 VIAL, SINGLE-DOSE in 1 CARTON (17478-189-24) / .3 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA212291 |
| FDA SPL set id | 656785 |
| Labeler | Akorn Operating Company LLC (dba Akorn) |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 17478-189 |
NDC Item 24208049605
| NDC 9 | 24208-496 |
|---|---|
| NDC 10 | 24208-496-05 |
| NDC Item | 24208049605 |
| Packaging | 4 POUCH in 1 CARTON (24208-496-05) / 15 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 554526 |
| Labeler | BAUSCH & LOMB INCORPORATED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2021-03-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 24208-496 |
NDC Item 42571039871
| NDC 9 | 42571-398 |
|---|---|
| NDC 10 | 42571-398-71 |
| NDC Item | 42571039871 |
| Packaging | 6 POUCH in 1 CARTON (42571-398-71) / 10 VIAL in 1 POUCH / .3 mL in 1 VIAL |
| ANDA | ANDA216596 |
| FDA SPL set id | 837331 |
| Labeler | Micro Labs Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 42571-398 |
NDC Item 50742028804
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-04 |
| NDC Item | 50742028804 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 50742028860
| NDC 9 | 50742-288 |
|---|---|
| NDC 10 | 50742-288-60 |
| NDC Item | 50742028860 |
| Packaging | 15 POUCH in 1 CARTON (50742-288-60) / 4 CONTAINER in 1 POUCH (50742-288-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-288 |
NDC Item 69918060160
| NDC 9 | 69918-601 |
|---|---|
| NDC 10 | 69918-601-60 |
| NDC Item | 69918060160 |
| Packaging | 60 POUCH in 1 CARTON (69918-601-60) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| ANDA | ANDA212592 |
| FDA SPL set id | 623687 |
| Labeler | Nordic Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69918-601 |
NDC Item 72485060205
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-05 |
| NDC Item | 72485060205 |
| Packaging | 0.3 mL in 1 VIAL |
| Packaging | 10 in 1 POUCH |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 72485060260
| NDC 9 | 72485-602 |
|---|---|
| NDC 10 | 72485-602-60 |
| NDC Item | 72485060260 |
| Packaging | 6 POUCH in 1 CARTON (72485-602-60) / 10 VIAL in 1 POUCH (72485-602-05) / .3 mL in 1 VIAL |
| ANDA | ANDA217195 |
| COLORTEXT | Yellow(light yellow) |
| Color | C48330 __ |
| FDA SPL set id | 841421 |
| Labeler | Armas Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72485-602 |
NDC Item 82260049605
| NDC 9 | 82260-496 |
|---|---|
| NDC 10 | 82260-496-05 |
| NDC Item | 82260049605 |
| Packaging | 6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINER |
| FDA SPL set id | 863545 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2022-02-17 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA019463 |
| Related queries | Properties for NDC 9 82260-496 |